XOMA Royalty (XOMA) Capital Expenditures (QoQ) (2010 - 2016)
XOMA Royalty (XOMA) Capital Expenditures (QoQ) (2010 - 2016) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,725.60 Bn | 68,725.31 Bn | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 472.73 Bn | 467.94 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.52 Bn | 116.27 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.74 Bn | 60.99 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - |
| 8 | Argenx Se | 56.42 Bn | 51.24 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.76 Bn | 37.76 Bn | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 186.11% |
| Dec 31, 2015 | -160.00% |
| Sep 30, 2015 | -66.85% |
| Jun 30, 2015 | -19.56% |
| Mar 31, 2015 | 129.59% |
| Dec 31, 2014 | -33.33% |
| Sep 30, 2014 | 374.19% |
| Jun 30, 2014 | -36.73% |
| Mar 31, 2014 | -51.00% |
| Dec 31, 2013 | -52.38% |
| Sep 30, 2013 | -41.83% |
| Jun 30, 2013 | -27.51% |
| Mar 31, 2013 | 20.87% |
| Dec 31, 2012 | -57.79% |
| Sep 30, 2012 | 70.33% |
| Jun 30, 2012 | 4.56% |
| Mar 31, 2012 | -23.68% |
| Dec 31, 2011 | 115.62% |
| Sep 30, 2011 | -75.60% |
| Jun 30, 2011 | 53.72% |